Christopher Bowden, Chief Medical Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 99,276 shares at $50.03 ($5.0M) on 2020-02-04, disclosed to the SEC on 2020-02-06.
Open-market sale of $5.0M AGIO by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.03 | 14,191 | $710K | 14.3% |
| 2 | $50.03 | 14,191 | $710K | 14.3% |
| 3 | $50.10 | 35,447 | $1.8M | 35.7% |
| 4 | $50.10 | 35,447 | $1.8M | 35.7% |
| Total | $50.08 avg | 99,276 | $5.0M | 100% |
| Filing → |
| AGIO | SELL | 2021-06-11 | $3.4M | — | Filing → |
| AGIO | SELL | 2021-06-09 | $1.3M | — | Filing → |
| AGIO | SELL | 2021-04-21 | $1.9M | — | Filing → |